跳至主要内容
临床试验/IRCT20180718040520N1
IRCT20180718040520N1已完成3 期

Evaluating effects of montelukast added to nasal mometasone in comparison to placebo in the treatment of children with adenoid hypertrophy

Tehran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 14 years(—)
性别
All

入选标准

  • hypertrophy of adenoids confirmed clinically and radiologically
  • Current use of nasal Mometason
  • No contraindication for corticosteroids or monteleukast
  • No previous adenoidectomy
  • Patients and parents consent
  • age 2 to 14 years

排除标准

  • Allergic to nasal corticosteroids or antileukotriens
  • Craniofacial, neuromuscular disorders or syndromes
  • Acute upper respiratory tract infection
  • Use of corticosteroids or antibiotics within last 2 weeks
  • drug reactions requiring medication change
  • patients who require surgical treatment while participating
  • patient or parent refusal

研究者

相似试验